\
Rapid PCR Covid Tests Available Now! Read More

Public Reporting

ACO Name and Location

Think ACO, LLC
Previous Names: N/A
7100 West Center Road
Omaha, NE 68106

ACO Primary Contact

Primary Contact NamePat Boyd
Primary Contact Phone Number531.222.8855
Primary Contact Email Addresspat.boyd@thinkhealthcare.org

Organizational Information

ACO Participants:

ACO ParticipantsACO Participant in Joint Venture (Enter Y or N)
Think Aksarben, LLCNo

ACO governing Body:

Member Last NameMember First NameMember Title/PositionMember’s Voting Power – Expressed as a percentage or numberMember TypeACO Participant Legal Business Name/DBA, If Applicable
CanedyJimACO Executive1ACO participant representativeThink Aksarben, LLC
EngleWilliamMedical Director1ACO participant representativeThink Aksarben, LLC
MancusoMartinPhysician1ACO participant representativeThink Aksarben, LLC
ReckerRobertPhysician1ACO participant representativeThink Aksarben, LLC
WeeksWilliamPhysician1ACO participant representativeThink Aksarben, LLC
DunnMichaelRetired Physician1Medicare beneficiary representative

Key ACO Clinical and Administrative Leadership:

ACO ExecutiveJim Canedy, MD
Medical DirectorWilliam Engle, DO
Compliance OfficerMike Demman
Quality Assurance/Improvement OfficerAmanda Payne

Associated Committees and Committee Leadership:

Committee NameCommittee Leader Name and Position
Population HealthWilliam Engle, DO, Medical Director
Quality Assurance and Quality ImprovementAmanda Payne, QA/QI Professional
Compensation/Gainshare CommitteeJason Doll, Chief Operating Officer

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2020, $1,493,375.13
    • Performance Year 2019, $2,843,195.84
  • First Agreement Period
    • Performance Year 2019, $2,843,195.84
    • Performance Year 2018, $0
    • Performance Year 2017, $2,412,663
    • Performance Year 2016, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings amount reported for Performance Year 2019 therefore represents net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution

  • Second Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2019
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • First Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results

2020 Quality Performance Results

ACO#Measure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)).66.95
ACO-13Falls: Screening for Future Fall Risk96.7796.7784.97
ACO-14Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))95.0876.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention75.8681.67
ACO-18Preventive Care and Screening: Screening for Depression and Follow-up Plan90.1271.46
ACO-19Colorectal Cancer Screening84.5472.59
ACO-20Breast Cancer Screening88.8774.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease88.8083.37
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control6.4114.70
ACO-28Hypertension (HTN): Controlling High Blood Pressure83.1972.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.
Skip to content